Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07477197 · ClinicalTrials.gov registry record
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
A clinical trial of Pulmonary Hypertension and Adult Congenital Heart Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT07477197: Recruiting study of Pulmonary Hypertension and Adult Congenital Heart Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT07477197 is a study of Pulmonary Hypertension and Adult Congenital Heart Disease that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 5,000 participants, above the 544-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (819% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07477197, a study of Pulmonary Hypertension and Adult Congenital Heart Disease, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A repository of biospecimens and detailed phenotypic information collected longitudinally from adults with congenital heart disease and related conditions, with an aim to facilitate future research on biologic mechanisms of underlying disease, compensation and deterioration; biologic correlates of patient experience and functional status; associations between clinical characteristics and various biomarkers; and predictors of clinical outcomes.
Primary Outcome
Defined as the number and type of biospecimens collected and successfully linked with corresponding clinical and phenotypic data.
Conditions Studied
Study Locations (1)
Ohio
- Children's Hospital Medical Center, Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2050-01-01 |
What NCT07477197 shows while recruiting
NCT07477197 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 544-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (819% higher).
The record links to 4 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT07477197 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07477197 about?
NCT07477197 is a clinical study titled "Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders". A repository of biospecimens and detailed phenotypic information collected longitudinally from adults with congenital heart disease and related conditions, with an aim to facilitate future research on biologic mechanisms of underlying disease, compensation and deterioration; biologic correlates of p...
What is the current status of trial NCT07477197?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2021-07-01. Estimated completion is 2050-01-01.
What conditions does trial NCT07477197 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Adult Congenital Heart Disease, Connective Tissue Disease, Other Cardiovascular Conditions.
Who is sponsoring clinical trial NCT07477197?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07477197 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07477197's enrollment target sits among peer trials
5,000 3rd of 72 higher than 70 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
-
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI